| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.03 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.067 | 0.03 |